These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 36041326)

  • 1. Decoding the effects of spike receptor binding domain mutations on antibody escape abilities of omicron variants.
    Chakraborty S; Saha A; Saha C; Ghosh S; Mondal T
    Biochem Biophys Res Commun; 2022 Oct; 627():168-175. PubMed ID: 36041326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omicron variant (B.1.1.529) of SARS-CoV-2: understanding mutations in the genome, S-glycoprotein, and antibody-binding regions.
    Bhattacharya M; Sharma AR; Dhama K; Agoramoorthy G; Chakraborty C
    Geroscience; 2022 Apr; 44(2):619-637. PubMed ID: 35258772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key mutations responsible for the enhancement of receptor-binding affinity and immune escape of SARS-CoV-2 Omicron variant.
    Wang WB; Ma YB; Lei ZH; Zhang XF; Li J; Li SS; Dong ZY; Liang Y; Li QM; Su JG
    J Mol Graph Model; 2023 Nov; 124():108540. PubMed ID: 37352723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron.
    Schröder S; Richter A; Veith T; Emanuel J; Gudermann L; Friedmann K; Jeworowski LM; Mühlemann B; Jones TC; Müller MA; Corman VM; Drosten C
    Virol J; 2023 Nov; 20(1):257. PubMed ID: 37940989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains.
    Starr TN; Greaney AJ; Stewart CM; Walls AC; Hannon WW; Veesler D; Bloom JD
    PLoS Pathog; 2022 Nov; 18(11):e1010951. PubMed ID: 36399443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.
    Yi C; Sun X; Lin Y; Gu C; Ding L; Lu X; Yang Z; Zhang Y; Ma L; Gu W; Qu A; Zhou X; Li X; Xu J; Ling Z; Xie Y; Lu H; Sun B
    Genome Med; 2021 Oct; 13(1):164. PubMed ID: 34649620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of SARS-CoV-2 omicron variant and its lineages by rapid detection of immune-escape mutations in spike protein RBD using asymmetric PCR-based melting curve analysis.
    Kong X; Gao P; Jiang Y; Lu L; Zhao M; Liu Y; Deng G; Zhu H; Cao Y; Ma L
    Virol J; 2023 Aug; 20(1):192. PubMed ID: 37626353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
    Cao Y; Yisimayi A; Jian F; Song W; Xiao T; Wang L; Du S; Wang J; Li Q; Chen X; Yu Y; Wang P; Zhang Z; Liu P; An R; Hao X; Wang Y; Wang J; Feng R; Sun H; Zhao L; Zhang W; Zhao D; Zheng J; Yu L; Li C; Zhang N; Wang R; Niu X; Yang S; Song X; Chai Y; Hu Y; Shi Y; Zheng L; Li Z; Gu Q; Shao F; Huang W; Jin R; Shen Z; Wang Y; Wang X; Xiao J; Xie XS
    Nature; 2022 Aug; 608(7923):593-602. PubMed ID: 35714668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin of the tight binding mode to ACE2 triggered by multi-point mutations in the omicron variant: a dynamic insight.
    Zhao X; Xiong D; Luo S; Duan L
    Phys Chem Chem Phys; 2022 Apr; 24(15):8724-8737. PubMed ID: 35373810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariants.
    Bhattacharya M; Chatterjee S; Lee SS; Dhama K; Chakraborty C
    Drug Resist Updat; 2023 Nov; 71():101008. PubMed ID: 37757651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omicron (B.1.1.529) - A new heavily mutated variant: Mapped location and probable properties of its mutations with an emphasis on S-glycoprotein.
    Chakraborty C; Bhattacharya M; Sharma AR; Mallik B
    Int J Biol Macromol; 2022 Oct; 219():980-997. PubMed ID: 35952818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution.
    Moulana A; Dupic T; Phillips AM; Chang J; Roffler AA; Greaney AJ; Starr TN; Bloom JD; Desai MM
    Elife; 2023 Feb; 12():. PubMed ID: 36803543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding Interactions between Receptor-Binding Domain of Spike Protein and Human Angiotensin Converting Enzyme-2 in Omicron Variant.
    Jawad B; Adhikari P; Podgornik R; Ching WY
    J Phys Chem Lett; 2022 May; 13(17):3915-3921. PubMed ID: 35481766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of SARS-CoV-2 Omicron BA.1 and BA.2 Variants to Vaccine-Elicited Sera and Therapeutic Monoclonal Antibodies.
    Zhou H; Dcosta BM; Landau NR; Tada T
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of Omicron immune evasion: A comparative computational study.
    Contractor D; Globisch C; Swaroop S; Jain A
    Comput Biol Med; 2022 Aug; 147():105758. PubMed ID: 35763933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 in relation to global vaccination and booster doses: what is the future of vaccination in the battle against COVID-19?
    Khalid N; Wheeler AM
    Bratisl Lek Listy; 2022; 123(9):631-633. PubMed ID: 36039880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.
    Dapporto F; Marchi S; Leonardi M; Piu P; Lovreglio P; Decaro N; Buonvino N; Stufano A; Lorusso E; Bombardieri E; Ruello A; Viviani S; Molesti E; Trombetta CM; Manenti A; Montomoli E
    J Immunol Res; 2022; 2022():4813199. PubMed ID: 36093434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocktail of REGN Antibodies Binds More Strongly to SARS-CoV-2 Than Its Components, but the Omicron Variant Reduces Its Neutralizing Ability.
    Nguyen H; Lan PD; Nissley DA; O'Brien EP; Li MS
    J Phys Chem B; 2022 Apr; 126(15):2812-2823. PubMed ID: 35403431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.